On February 15, 2017, the European Parliament voted to approve the Canada-EU Comprehensive Economic and Trade Agreement (CETA).

The Indian Controller of Patents granted a Compulsory Licence to Natco Pharma Limited for Bayer’s NEXAVAR sorafenib product.

As part of Canada's commitment to intellectual property, the National Research Council offers an IP Assist program, including financial support, for qualifying start-ups.

What is intellectual property (IP), and how do you protect it? In this video series, we will explain what IP is, the types of IP your organization may have, and tips and practical considerations...

What is intellectual property (IP), and how do you protect it? In this video series, we will explain what IP is, the types of IP your organization may have, and tips and practical considerations to help you protect, enforce.

What is intellectual property (IP), and how do you protect it?

In this peer reviewed editorial for Informa Healthcare, Carmela De Luca discusses a recent agreement between Merck and The Medicines Patent Pool to license intellectual property relating to pediatric formulations of its integrase HIV drug.

As previously reported, the Federal Court of Appeal (FCA) dismissed Millennium Pharmaceuticals and Janssen's appeal from a decision granting Teva's claim for...

Montenegro is set to become the newest member state of the European Patent Organization (EPO) in October 2022.

In this video, Shahrzad Esmaili and Grant Tisdall discuss how to avoid common pitfalls with intellectual property and offer tips on streamlining the patent process.

This informative podcast breaks down the key developments of AI in chemistry and explores the nuances of intellectual property in the field of Chemical AI.

We previously reported on proposed amendments to the Patented Medicines Regulations released on December 2, 2017.

On October 26, 2017, the Federal Minister of Health tabled the 2016 Annual Report of the PMPRB with the Clerks of the House of Commons and the Senate.

In the third of four videos from the Canadian Lawyer InHouse View 2017 series...

The Canadian Intellectual Property Office has released guidance on "Computer-Implemented Inventions" as planned, in the wake of the Federal Court of Appeal decision in Amazon.

On October 7, 2021, the Supreme Court of Canada denied leave to Apotex.

On June 14, 2012, the Supreme Court of Canada ("SCC") denied leave to hear an appeal involving section 8 of the Patented Medicines (Notice of Compliance) Regulations.

In a recent decision that could significantly affect the biotechnology industry, the United States Supreme Court in Association for Molecular Pathology v. Myriad Genetics, Inc., No. 12-398, held that "a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated."

Andrew Moeser will be sharing his expertise on patent enforcement at the joint Intellectual Property Institute of Canada and McGill University Summer IP Course. Andrew will lead a discussion...

Earlier this year we reported on a decision of the Federal Court of Appeal in which the University of Alberta sought to revive an abandoned patent application after the reinstatement period had expired.